The suppression of two genes reduce breast cancer tumor formation and metastasis by interfering with blood vessel formation and recruitment. This was reported by scientists from Houston Methodist and five other institutions in the iProceedings of the National Academy of Sciences/i (now online). The findings may help medical researchers identify effective drug targets for triple negative breast cancer, or TNBC. The genes, MLF2 (myeloid leukemia factor ...
Read More
You have just read an article categorized health
titled Two New Drug Targets for Triple Negative Breast Cancer.
Written by:
editor -
Tuesday, May 27, 2014
There are currently no comments for "Two New Drug Targets for Triple Negative Breast Cancer"
Post a Comment